Jump Financial’s Charles River Laboratories CRL Stock Holding History

Jump Financial’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,953	Closed	-$1.4M	–	1995
2025 Q3	$1.4M	Buy	+8,953	New	+$1.42M	0.02%	856
2025 Q1	–	Sell	-14,794	Closed	-$2.73M	–	1646
2024 Q4	$2.73M	Buy	+14,794	New	+$2.85M	0.06%	425
2024 Q3	–	Sell	-4,118	Closed	-$851K	–	1711
2024 Q2	$851K	Buy	4,118 +3,052	+286%	+$692K	0.02%	891
2024 Q1	$289K	Buy	+1,066	New	+$255K	0.01%	1467
2023 Q4	–	Sell	-1,033	Closed	-$202K	–	1860
2023 Q3	$202K	Sell	1,033 -834	-45%	-$171K	0.01%	1518
2023 Q2	$393K	Buy	1,867 +653	+54%	+$130K	0.01%	1150
2023 Q1	$245K	Buy	+1,214	New	+$275K	0.01%	1220
2022 Q4	–	Sell	-6,865	Closed	-$1.35M	–	1641
2022 Q3	$1.35M	Buy	+6,865	New	+$1.48M	0.05%	503
2022 Q2	–	Sell	-7,004	Closed	-$1.99M	–	1680
2022 Q1	$1.99M	Buy	+7,004	New	+$2.16M	0.08%	286

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Jump Financial's CRL Position: Q4 2025 in Review

Jump Financial sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 8,953 shares — an estimated $1.4M sold.

Jump Financial first reported a position in CRL in Q1 2022 and held it in 9 quarters. The position peaked at $2.73M in Q4 2024. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

Jump Financial reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
Jump Financial sold 8,953 Charles River Laboratories shares in Q4 2025, an estimated $1.4M.
Jump Financial first reported a position in Charles River Laboratories in Q1 2022 and held it in 9 quarters.
Jump Financial's Charles River Laboratories position peaked at $2.73M in Q4 2024.
580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Jump Financial's 13F filing for Q4 2025, filed 17 Feb 2026.